Back to Search Start Over

Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition.

Authors :
Kücükdisli M
Bel-Abed H
Cirillo D
Lo WT
Efrém NL
Horatscheck A
Perepelittchenko L
Prokofeva P
Ehret TAL
Radetzki S
Neuenschwander M
Specker E
Médard G
Müller S
Wilhelm S
Kuster B
von Kries JP
Haucke V
Nazaré M
Source :
Journal of medicinal chemistry [J Med Chem] 2023 Oct 26; Vol. 66 (20), pp. 14278-14302. Date of Electronic Publication: 2023 Oct 11.
Publication Year :
2023

Abstract

Class II phosphoinositide-3-kinases (PI3Ks) play central roles in cell signaling, division, migration, and survival. Despite evidence that all PI3K class II isoforms serve unique cellular functions, the lack of isoform-selective inhibitors severely hampers the systematic investigation of their potential relevance as pharmacological targets. Here, we report the structural evaluation and molecular determinants for selective PI3K-C2α inhibition by a structure-activity relationship study based on a pteridinone scaffold, leading to the discovery of selective PI3K-C2α inhibitors called PITCOINs. Cocrystal structures and docking experiments supported the rationalization of the structural determinants essential for inhibitor activity and high selectivity. Profiling of PITCOINs in a panel of more than 118 diverse kinases showed no off-target kinase inhibition. Notably, by addressing a selectivity pocket, PITCOIN4 showed nanomolar inhibition of PI3K-C2α and >100-fold selectivity in a general kinase panel. Our study paves the way for the development of novel therapies for diseases related to PI3K-C2α function.

Details

Language :
English
ISSN :
1520-4804
Volume :
66
Issue :
20
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
37819647
Full Text :
https://doi.org/10.1021/acs.jmedchem.3c01319